Colpitts Clinical a Direct Travel company Revenue and Competitors

Norwood, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Colpitts Clinical a Direct Travel company's estimated annual revenue is currently $4.3M per year.(i)
  • Colpitts Clinical a Direct Travel company's estimated revenue per employee is $155,000

Employee Data

  • Colpitts Clinical a Direct Travel company has 28 Employees.(i)
  • Colpitts Clinical a Direct Travel company grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Colpitts Clinical a Direct Travel company?

Colpitts Clinical, a Direct Travel company, offers specialized clinical trial travel logistics and expense management, and was one of the first travel companies to provide clinical patients’ care beginning more than 15 years ago. Colpitts now services a number of leading biotechnology, pharmaceutical organizations, and CRO’s around the world. Colpitts understands the importance of providing a personal and confidential service to clinical trial patients when organizing their travel and expense reimbursement. Colpitts’ solid foundation is critical in today’s world economy. Our clients can be confident of our longevity in the travel industry. Colpitts has built strong personal relationships with numerous air carriers, hotel, and sedan transfer vendors in North America, Europe and around the globe. These associations ensure that clients receive the best rates and service.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M288%N/A
#2
$5.3M284%N/A
#3
$2.8M2856%N/A
#4
$2M297%N/A
#5
$4.3M30-9%N/A